ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Melinta Announces Termination of Merger Agreement for Tetraphase
July 03, 2020Melinta Therapeutics announced pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp. -
FDA Approves Tetraphase's XERAVA
August 29, 2018Tetraphase Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted approval of XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections (cIAI). -
Tetraphase enters into agreement with Biopharma firm in China
February 26, 2018As per the agreement, Tetraphase will receive an initial upfront payment of $7.0 million and may receive clinical and regulatory milestones of up to $16.5 million as well as annual sales milestones of up to $20.0 million.
Pharma Sources Insight January 2025
